Solicitation of Assays for High Throughput Screening (HTS) in the Molecular Libraries Screening Centers Network (R03)

The summary for the Solicitation of Assays for High Throughput Screening (HTS) in the Molecular Libraries Screening Centers Network (R03) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Solicitation of Assays for High Throughput Screening (HTS) in the Molecular Libraries Screening Centers Network (R03): -Purpose. This FOA promotes discovery and development of new chemical probes as research tools for use by scientists in both the public and private sector to advance the understanding of biological functions and disease mechanisms. This initiative is one of the integrated components of the NIH Molecular Libraries Roadmap initiative that offers biomedical researchers access to large-scale automated high throughput screening (HTS) centers in the Molecular Libraries Screening Centers Network (MLSCN), diverse compound libraries in the Small Molecule Repository (MLSMR) and information on biological activities of small molecules in the PubChem BioAssay public database. The purpose of this FOA is to solicit HTS assays from the scientific community by identifying investigators who have the interest and capability to work with the molecular libraries screening centers in support of chemical probe development. -Mechanism of Support. This FOA uses the NIH Small Research Grant (R03) award mechanism and runs in parallel with PAR-06-259 that solicits applications for MLSCN under the Resource Access (X01) award mechanism. -Although the R03 mechanism typically does not require preliminary data, for this FOA preliminary data are required for reviewer evaluation of the primary assay. The application must provide a description of a well-developed assay that can be automated for HTS and a systematic plan, including secondary and counter-screening assays, for evaluating active compounds identified in the primary HTS. The application should also include a strategy for further testing, in collaboration with the MLSCN center, to provide a final refinement in structure and function of the active compounds and leading to the optimum chemical probe.
Federal Grant Title: Solicitation of Assays for High Throughput Screening (HTS) in the Molecular Libraries Screening Centers Network (R03)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-06-545
Type of Funding: Grant
CFDA Numbers: 93.310
CFDA Descriptions: Trans-NIH Research Support
Current Application Deadline: No deadline provided
Original Application Deadline: Oct 27, 2007
Posted Date: Sep 07, 2006
Creation Date: Sep 07, 2006
Archive Date: Nov 26, 2007
Total Program Funding: $3,700,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification) Public and State controlled institutions of higher education Small businesses Special district governments Public housing authorities/Indian housing authorities City or township governments Independent school districts County governments Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility
Foreign institutions are not eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply. Applicants may submit more than one application, provided each application is scientifically distinct. One application can contain parallel screens for multiple related molecular targets or cellular systems within a screening plan.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Limited Competition: NIH Coordination and Evaluation Center for Enhancing the Diversity of...
National Research Mentoring Network (NRMN) Coordination Center (U24 - Clinical Trial Not A...
National Research Mentoring Network (NRMN) Resource Center (U24 - Clinical Trial Not Allow...
National Research Mentoring Network: The Science of Mentoring, Networking, and Navigating ...
The Human BioMolecular Atlas Program (HuBMAP) Integration, Visualization and Engagement (H...
Using Metabolomics to Investigate Biological Pathways and Networks (R01)
Assay Development for High Throughput Molecular Screening (R21)
Membrane Protein Production and Structure Determination (R01)
More Grants from the National Institutes of Health
Coordinating Center to Support NIDA Rural Opioid HIV and Comorbidity Initiative (U24 - Cli...
Sexually Transmitted Infections (STI) Cooperative Research Centers (CRC): Vaccine Developm...
Novel Tools for Investigating Brain-derived GPCRs in Mental Health Research (R43/R44 Clini...
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R01 Clinica...
Genomic Centers for Infectious Diseases (U19 Clinical Trial Not Allowed) is not endorsed by, or affiliated with, any government agency. Copyright ©2018